The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking.
Abstract
We previously demonstrated that membrane type 1 (MT1) matrix metalloproteinase (MMP) was up‐regulated in the hippocampus of the model of transgenic mice bearing 5 familial mutations on human amyloid precursor protein (APP) and presenilin 1 of Alzheimer disease (AD), and that the proteinase increased the levels of amyloid β peptide (Aβ) and its APP C‐terminal fragment of 99 aa in a heterologous cell system. Here we provide further evidence that MT1‐MMP interacts with APP and promotes amyloidogenesis in a proteolytic‐dependent manner in Swedish APP‐expressing human embryonic kidney 293 (HEKswe) cells. MT1‐MMP–mediated processing of APP releases a soluble APP fragment, sAPP95. This process partly requires the activation of endogenous MMP‐2 but is independent of β‐site APP cleaving enzyme 1 (BACE‐1) or α‐secretase activities. In contrast, MT1‐MMP–mediated increase of Aβ levels involved BACE‐1 activity and was inhibited by tissue inhibitor of MMP‐2, a natural inhibitor of both MT1‐MMP and MMP‐2. Interestingly, near abolishment of basal Aβ production upon BACE‐1 inhibition was rescued by MT1‐MMP, indicating that the latter could mimic β‐secretase–like activity. Moreover, MT1‐MMP promoted APP/Aβ localization in endosomes, where Aβ production mainly occurs. These data unveil new mechanistic insights to support the proamyloidogenic role of MT1‐MMP based on APP processing and trafficking, and reinforce the idea that this proteinase may become a new potential therapeutic target in AD.—Paumier, J.‐M., Py, N. A., González, L. G., Bernard, A., Stephan, D., Louis, L., Checler, F., Khrestchatisky, M., Baranger, K., Rivera, S. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP‐2 and BACE‐1 activities, and the modulation of APP trafficking. FASEB J. 33, 2910–2927 (2019). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MT1-MMP upregulation in 5xFAD mice timely and spatially correlates with the increase in C99 levels, providing indirect in vivo support for the pro-amyloidogenic features of this MMP described in HEKswe cells.
“MT1-MMP upregulation in 5xFAD mice timely and spatially correlates with the increase in C99 levels (Py et al., 2014), thus providing indirect in vivo support for the pro-amyloidogenic features of this MMP described in HEKswe cells (Paumier et al., 2019).”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Paumier et al., 2019
About 50% of the sAPP95 released after MT1-MMP expression in HEKswe cells results from concerted action with MMP-2, MT1-MMP being the limiting factor in this enzymatic tandem.
“It is estimated that about 50% of the sAPP95 released after MT1-MMP expression in HEKswe cells results from concerted action with MMP-2, MT1-MMP being in any case the limiting factor in this enzymatic tandem (Paumier et al., 2019).”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Paumier et al., 2019
MT1-MMP can prominently increase Aβ levels in the HEK293 cell model of amyloidogenesis stably expressing APP with the familial Swedish mutation (HEKswe).
“In complement of these results, we have recently reported that MT1-MMP can also prominently increase Aβ levels in the HEK293 cell model of amyloidogenesis, which stably expresses APP with the familial Swedish mutation (HEKswe) (Paumier et al., 2019).”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Paumier et al., 2019
MT1-MMP could function as a surrogate β-secretase when BACE-1 is inhibited; this is supported by experiments in HEKswe cells where MT1-MMP restores basal levels of Aβ almost abolished by BACE-1 inhibitor IV (or C3).
“Most interestingly, it has been proposed that MT1-MMP could also function as a surrogate β-secretase when BACE-1 is inhibited; this is supported by experiments in HEKswe cells where MT1-MMP is able to restore the basal levels of Aβ, almost abolished in the presence of BACE-1 inhibitor IV (or C3) (Paumier et al., 2019).”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Paumier et al., 2019
MT1-MMP could favor amyloidogenic β-secretase processing by promoting APP sorting into BACE-1-enriched early endosomes.
“Not exclusively, MT1-MMP could favor amyloidogenic β-secretase processing by promoting APP sorting into BACE-1-enriched early endosomes (Paumier et al., 2019).”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Paumier et al., 2019
The complementary transmembrane fragment of ~30 kDa (CTF-30) and C99 are dramatically increased and their levels highly correlated, suggesting that CTF-30 may be the precursor of C99.
“The complementary transmembrane fragment of ∼30 kDa (CTF-30) and C99 are also dramatically increased and their levels highly correlated, suggesting that CTF-30 may be the precursor of C99 (Paumier et al., 2019).”
From Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP (2019) · cites this paper as Paumier et al., 2019
For each experiment, cDNA samples were analyzed in duplicate and relative gene expression was obtained using the comparative 2−(ΔΔCt) method after normalization to the Gapdh housekeeping gene.
“For each experiment, cDNA samples were analyzed in duplicate and relative gene expression was obtained using the comparative 2−(ΔΔCt) method after normalization to the Gapdh (Mm99999915_g1) housekeeping gene [32, 33].”
MT1-MMP, MMP-9 and MMP-2 are close MT5-MMP homologues involved in the control of APP metabolism and amyloidogenesis.
“all close MT5-MMP homologues, also involved in the control of APP metabolism and amyloidogenesis [33, 34, 54, 55]”
Citations
Cites
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., & Arancio, O. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2692-08.2008 · Cited by 740
Not just amyloid: physiological functions of the amyloid precursor protein family
Müller, U. C., Deller, T., & Korte, M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.29 · Cited by 634
Kuhn, P., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., Kremmer, E., Roßner, S., & Lichtenthaler, S. F. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.167 · Cited by 621
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455
η-Secretase processing of APP inhibits neuronal activity in the hippocampus
Willem, M., Tahirovic, S., Busche, M. A., Ovsepian, S. V., Chafai, M., Kootar, S., Hornburg, D., Evans, L. D. B., Moore, S., Daria, A., et al. (2015) · Nature · doi:10.1038/nature14864 · Cited by 398
Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ
Yan, P., Hu, X., Song, H., Yin, K., Bateman, R. J., Cirrito, J. R., Xiao, Q., Hsu, F. F., Turk, J. W., Xu, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602440200 · Cited by 380
Ferreira, S. T., Lourenco, M. V., Oliveira, M. M., & De Felice, F. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00191 · Cited by 373
Lauritzen, I., Pardossi-Piquard, R., Bourgeois, A., Pagnotta, S., Biferi, M.-G., Barkats, M., Lacor, P., Klein, W., Bauer, C., & Checler, F. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1577-6 · Cited by 219
Self-citationLauritzen, I., Pardossi-Piquard, R., Bauer, C., Brigham, E., Abraham, J.-D., Ranaldi, S., Fraser, P., St-George-Hyslop, P., Le Thuc, O., Espin, V., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2775-12.2012 · Cited by 201
Self-citation
Flagged first, then by citations
Research works printed but not linked: 52
- 10.15252/emmm.201606210 · DOI · Paper page
- 10.1016/S0006-8993(00)02869-9 · DOI
- 10.1101/cshperspect.a006270 · DOI · Paper page
- 10.1186/1750-1326-9-48 · DOI
- 10.1016/j.neurobiolaging.2017.09.008 · DOI · Paper page
- 10.1111/j.1471-4159.2011.07584.x · DOI
- 10.1038/85064 · DOI
- 10.1016/B978-0-444-63486-3.00014-1 · DOI · Paper page
- 10.1016/0014-5793(96)00389-4 · DOI · Paper page
- 10.1074/jbc.275.16.12080 · DOI
- 10.1006/bbrc.1994.2872 · DOI
- Py N. A., 2014, Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP, Front. Aging Neurosci., 6, 247
- 10.1093/jb/mvj054 · DOI · Paper page
- 10.1007/s00018-015-1992-1 · DOI · Paper page
- Baranger K., 2017, MT5-MMP promotes Alzheimer's pathogenesis in the frontal cortex of 5xFAD mice and APP trafficking in vitro, Front. Mol. Neurosci., 9, 163, 10.3389/fnmol.2016.00163 · DOI · Paper page
- 10.1002/ijc.20459 · DOI
- 10.3727/096368912X657468 · DOI
- 10.1016/j.mcn.2008.08.004 · DOI
- 10.1371/journal.pone.0008289 · DOI
- 10.1074/jbc.M302622200 · DOI
- 10.1111/j.1365-2818.2006.01706.x · DOI
- 10.1186/1471-2202-6-68 · DOI · Paper page
- 10.1021/jm049379g · DOI · Paper page
- 10.1074/jbc.M200655200 · DOI · Paper page
- 10.1074/jbc.271.29.17119 · DOI
- 10.1042/bj3340345 · DOI
- 10.1111/j.1432-1033.1997.00751.x · DOI
- 10.1242/jcs.00063 · DOI
- 10.1126/scisignal.127re6 · DOI
- 10.1074/jbc.272.35.22086 · DOI
- 10.1074/jbc.M212264200 · DOI
- 10.1038/cddiscovery.2017.36 · DOI
- 10.1073/pnas.241293698 · DOI
- 10.1242/jcs.00710 · DOI
- 10.1021/bi901994d · DOI · Paper page
- 10.1016/j.bbamcr.2017.05.013 · DOI
- 10.1074/jbc.M111.252718 · DOI · Paper page
- 10.1074/jbc.M112.395608 · DOI · Paper page
- Bylander J. E., 2007, Human and mouse homo-oligomeric meprin A metalloendopeptidase: substrate and inhibitor specificities. Biol, Chem., 388, 1163
- 10.1038/nn.2433 · DOI · Paper page
- 10.1523/JNEUROSCI.3467-10.2010 · DOI · Paper page
- 10.1111/j.1600-0854.2012.01332.x · DOI · Paper page
- 10.1016/j.cell.2016.05.020 · DOI · Paper page
- 10.1242/jcs.00643 · DOI · Paper page
- 10.1126/science.286.5440.735 · DOI · Paper page
- 10.1073/pnas.1100745108 · DOI
- Dunys J. Valverde A. andChecler F.(In press)Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease? [E-pub ahead of print]J. Biol. Chem
- 10.1523/JNEUROSCI.2085-06.2006 · DOI · Paper page
- 10.1074/jbc.274.27.18851 · DOI
- 10.1016/j.bbrc.2011.08.085 · DOI
- 10.1074/jbc.M113.481101 · DOI · Paper page
- 10.1038/ncomms9762 · DOI · Paper page
Cited by
Sorted by citations
Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges
Zipfel, P., Rochais, C., Baranger, K., Rivera, S., & Dallemagne, P. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00352 · Cited by 94
Self-citationGarcía-González, L., Pilat, D., Baranger, K., & Rivera, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00244 · Cited by 88
Self-citationPilat, D., Paumier, J.-M., García-González, L., Louis, L., Stephan, D., Manrique, C., Khrestchatisky, M., Di Pasquale, E., Baranger, K., & Rivera, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02407-z · Cited by 28
Self-citation
Metadata
- Authors
- Paumier, J.-M., Py, N. A., García-González, L., Bernard, A., Stephan, D., Louis, L., Checler, F., Khrestchatisky, M., Baranger, K., & Rivera, S.
- Affiliations
- Aix-Marseille Univ CNRS INP Inst Neurophysiopathol Marseille France
- Institut de Pharmacologie Moléculaire et Cellulaire (IPMC) Unité Mixte de Recherche (UMR) 7275 CNRS–Université Nice Sophia (UNS) Excellence Laboratory (Labex) Development of Innovaive Strategies for a Transdisciplinary Approach to Alzheimer's Disease (DistAlz) Valbonne France
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2018-10-17
- Volume
- 33
- Issue
- 2
- Pages
- 2910-2927
- ISSN
- 0892-6638
- 1530-6860
- Cited by
- 40
- References
- 9
- Language
- en
- Funders
- Centre National de la Recherche Scientifique
- Aix-Marseille Université
- Agence Nationale de la Recherche
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review